# Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin

> **NCT00031291** · — · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 400 (—)

## Conditions studied

- Anthrax

## Interventions

- **DRUG:** Anthrax Immune Globulin

## Key facts

- **NCT ID:** NCT00031291
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 400 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031291, "Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00031291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*